Hikma Still Sees Value In Generic Advair Despite Teva’s US Approval
CEO Predicts Launch From Teva Later This Year; Also Comments On Vascepa Competition
• By David Wallace
Three firms could soon be competing for a slice of the US generic Advair market • Source: YesPhotographers / Alamy Stock Photo 
